November 02, 2025

Get In Touch

AIIMS Bhopal Conducts Brainstorming Session On Pediatric Blood Cancer Diagnosis, Treatment

Bhopal: The All India Institute of Medical Sciences (AIIMS) Bhopal recently organized a two-day brainstorming session focused on advanced technologies and innovative strategies for improving the diagnosis and treatment of blood cancer in children.
According to an IANS report, more than 50 doctors from across the country, including from AIIMS New Delhi delivered lectures and shared their experiences during the two-day long session concluded on Saturday.
Read also: Delhi AIIMS to get new Jan Aushadhi Kendra on October 29
The session aimed to foster collaboration among specialists, including pathologists, paediatricians, and pediatric oncologists, to ensure better outcomes for young patients.
During the discussion, Executive Director of AIIMS Bhopal Dr. Ajay Singh highlighted the importance of collaboration among medical professionals on this serious issue. He noted the treatment of childhood cancer requires a multidisciplinary approach.
"Collaboration between pathologists, paediatricians, and pediatric oncologists is extremely important for correct diagnosis and effective treatment of blood cancer in children," he said while addressing the gathering of doctors and medical students.
Briefing about the multi-layer process of diagnosis, Dr. Singh noted that paediatricians typically suspect blood cancer based on symptoms such as prolonged fever, bleeding, nodular swelling, abdominal swelling, and difficulty in breathing while pathologists then confirm the diagnosis by identifying cancer cells in the blood, and the exact type of blood cancer is determined through specialised tests.
"Pediatric oncologists, in collaboration with pathologists and molecular oncologists, create individualised treatment plans based on the child's risk group to ensure the appropriate dose of chemotherapy," Dr Singh said, news agency IANS reported.
He advised practising doctors and medical students that an excessively high dose can lead to additional side effects and costs, while a low dose may increase the risk of cancer recurrence.
Dr. Singh asserted that the collaboration and exchange of knowledge among various specialists are expected to lead to more precise and effective treatment strategies for blood cancers in children.
"Such meetings are essential to understand each other's viewpoints and improve patient care, which is part of the mission of AIIMS Bhopal. I congratulate the departments of pathology and paediatrics for this important initiative to enhance the quality of healthcare provided to our young patients," he said.
He also noted that the joint meeting represents a significant step in AIIMS Bhopal's ongoing efforts to provide cutting-edge technologies in cancer care and promote a multidisciplinary approach to treating complex conditions.
Read also: AIIMS Bhopal Launches MSc Program in Translational Medicine

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!